BCLI: BrainStorm Cell Therapeutics Inc. PEG multiplikatori
Brainstorm Cell (BCLI) NurOwn platformasiga e'tibor qaratadi, u yerda III bosqich ALS terapiyasi sinovlari va FDA bilan hamkorlik asosiy o'sish drayverlariga aylandi. Yetakchi neyrobiologlarning ishi asosidagi PEG ko'rsatkichi parametr qiymati 0.00 ga yetishini ko'rsatmoqda. NurOwn mahsulotining inqilobiy davolash vositasi sifatidagi istiqbollari kompaniyaning neyromeditsina sektoridagi joriy salohiyatini belgilaydi.
Brainstorm Cell (BCLI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Brainstorm Cell|BCLI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati brainstorm-cell.com|BCLI - Kompaniya qarzlari|Balans qiymatiga qarzlar Brainstorm Cell|BCLI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari BrainStorm Cell Therapeutics|Tezkor likvidlik ko‘rsatkichi brainstorm-cell.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
BCLI - Sof daromad|Kutilayotgan sof daromad Brainstorm Cell|BCLI - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati BrainStorm Cell Therapeutics Inc.|BCLI - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Brainstorm Cell|BCLI - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda BrainStorm Cell Therapeutics|BCLI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi brainstorm-cell.com|BCLI - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Brainstorm Cell
Kompaniyaning fundamental tahlili:BCLI - Brainstorm Cell Therapeutics Inc.
Brainstorm Cell (BCLI) kompaniyasining neyrodegenerativ kasalliklarni davolashga mo‘ljallangan diversifikatsiyalashgan hujayra terapiyasi loyihalari tartibga soluvchi o‘zgarishlar bilan bog‘liq xavflarni kamaytiradi, bu esa PEG koeffitsiyenti grafigining tahlilini juda muhim qiladi. Ushbu ko‘rsatkich joriy P/E koeffitsiyentini foyda o‘sish sur’atlari bilan solishtiradi, bu esa investorlarga fundamental past baholanganlikni "qiymat tuzog‘i"dan ajratish imkonini beradi; birdan past qiymat kompaniyaning daromad dinamikasiga nisbatan aksiyalar narxining o‘sish potentsialini anglatadi.
Brainstorm Cell raqobatchilari
BIIB (Biogen Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|PEG multiplikatori Regencell Corp RGC|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acadia-pharm.com ACAD|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|Catalyst Corp (CPRX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HRMY|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori ceribell.com|Narx-foyda va o‘sish multiplikatori PRTA|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANNX|Narx-foyda va o‘sish multiplikatori omeros.com OMER|PEG multiplikatori NGNE (Neurogene Inc.)|acimmune.com (ACIU) - O‘sish sur’atiga tuzatilgan narx-foyda|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|NMRA: Narxning foydaga va o‘sish sur’atiga nisbati|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|TVGN (Tevogen Bio Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Inc) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati CGTX|PEG multiplikatori IKT|Narx-foyda va o‘sish multiplikatori Cassava Sciences Inc SAVA|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|Coya Therapeutics Inc - Narxning foydaga va o‘sish sur’atiga nisbati|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics Inc. OVID|Acumen Pharmaceuticals, Inc. (ABOS) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CRVO|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Clene Nanomedicine CLNN|Narx-foyda va o‘sish multiplikatori PEPG (PepGen Inc.)|PEG multiplikatori jupiterneurosciences.com (JUNS)|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ANVS|GRCE - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Firefly Neuro|KLTO: PEG multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|MTVA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NRXS|PEG multiplikatori heliusmedical.com (HSDT)|PEG multiplikatori PASG (Passage Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neuphoria Therapeutics, Inc. (NEUP)|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|ATHA (Athira Pharma Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Addex Therapeutics, Ltd. (ADXN) - Narxning foydaga va o‘sish sur’atiga nisbati|ALZN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori CYCN|PTIX (Protagenic) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|CRGT - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Avenue Therapeutics, Inc ATXI|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CARA|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|Eliem Therapeutics (ELYM) - Narx-foyda va o‘sish multiplikatori|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|Longboard Pharmaceuticals Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|MRNS (Marinus) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori NKGen Biotech Corp (NKGN)|PEG multiplikatori NRBO|SAGE - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Synaptogenix SNPX|Trevena Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|WENA: Narxning foydaga va o‘sish sur’atiga nisbati|CERE: PEG multiplikatori
